Exit

Purpose of the Survey

This survey aims to gather information about owner experience with the use of SGLT2 inhibitors in equines with metabolic disorders (EMS/PPID). Your answers will be entered into a private database that may be used to improve understanding of the effects of SGLT2 inhibitors in EMS/PPID. You will not be identified and no personal information will be shared.

If you have copies of equine blood tests and forage analysis, having these nearby while you complete the survey will help.

Question Title

* 1. Are you a member of the ECIR Outreach Group?

Question Title

* 2. Do you have a case history with the ECIR Outreach Group?

Question Title

* 3. If relevant, provide a link to your case history (paste in text box)

Question Title

* 4. Equine Name

Question Title

* 5. Equine age in years (no decimals or months, please)

Question Title

* 6. Breed

Question Title

* 7. Equine Weight (specify pounds or kilograms), estimate if unknown

Question Title

* 8. Equine Body Condition

Question Title

* 9. Equine Sex

Question Title

* 10. Does your equine have EMS and/or PPID (Cushing's)? If NO, please exit survey)

Question Title

* 11. If your equine has PPID, is ACTH controlled, i.e., blood tests confirm that ACTH is within acceptable seasonal limits?

Question Title

* 12. Date SGLT2 inhibitor treatment started.

Date

Question Title

* 13. Which SGLT2 inhibitor drug are you currently using? If you have used more than one, select them in the next question.

Question Title

* 14. What was the starting dose? You may select mg/day or tablets/paste. If you started with one drug, then switched to another, select both. If unsure, give details in the comments box.

  mg/kg Tablets/Paste Tablets per day (or dose of paste per day)
Canagliflozin (Invokana)
Ertugliflozin (Steglatro)
Dapagliflozin (Forxiga)

Question Title

* 15. Were there changes to the dose over time?

Question Title

* 16. If there were changes to the dose or drug, please list the drug name, date(s) and dose where changes were made. Skip if no change was made. Ex: 01/01/2024, switched to Invokana, 0.03 mg/kg OR 01/01/24, stopped Invokana, started Steglatro 0.025 mg/kg.

Question Title

* 17. Before starting treatment with an SGLT2 inhibitor, did your equine have blood glucose over 100 mg/dL (5.5 mmol/L)?

Question Title

* 18. Were blood triglycerides tested prior to starting the drug?

Question Title

* 19. If triglycerides were tested before starting, what was the result? Please specify units of measure, either mmol/L or mg/dL

Question Title

* 20. Were liver enzymes measured prior to starting the drug?

Question Title

* 21. If liver enzymes were measured, what were the results? Since there are multiple liver enzymes, simply list normal, abnormal or don't know.

Question Title

* 22. Was triglyceride testing repeated? If yes, please enter date (MM/DD/YYYY) and results with the unit of measure (mmol/L or mg/dL)

Question Title

* 23. Was liver enzyme testing repeated? If yes, please list date (MM/DD/YYYY) below followed by result. Since there are multiple liver enzyme results, simply state "Normal" "Abnormal" or "I don't know."

Question Title

* 24. Was the equine fasted for blood tests?

Question Title

* 25. When you started using the drug, what was the daily hay ration? Please list by weight only (no flakes!) and specify either pounds or kilograms. If free choice feeding, select "Other."

  Pounds Kilograms
Hay

Question Title

* 26. Do you have a forage analysis?

Question Title

* 27. If you have a forage analysis, we would like to know the WSC, ESC, and starch in the AS FED or AS SAMPLED column. Some labs list only dry matter (one column). Note that some labs use the term "sugar" (ESC) or may not measure one of the above. Leave blank if unknown. Enter percent moisture at the bottom.

  %WSC %ESC %Starch
As Fed or As Sampled Results
Dry Matter Results

Question Title

* 28. Do you feed other feeds, for example, beet pulp, commercial feed (list brand), forage cubes or pellets? List product(s) followed by TOTAL DAILY amount in lbs or kg (no scoops!) Ex: Beet Pulp, 1 lb.

Question Title

* 29. Do you use a vitamin mineral supplement?

Question Title

* 30. Did your equine lose weight while on this drug without any intentional changes to the diet?

Question Title

* 31. Did you find that you needed to make changes to the diet after starting the drug?

Question Title

* 32. If you had to make changes to the diet, please explain why and what changes you had to make. Ex: added protein, amino acids, glycine, etc.

Question Title

* 33. Were there any other side effects that you think might be related to treatment with SGLT2 inhibitor drugs?

Question Title

* 34. Thank you for participating. Please list anything else you would like us to know about your experience using this type of drug, e.g., overall satisfaction, concerns, etc.

Question Title

* 35. Are you willing to share your contact information should we have more questions?

Question Title

* 36. If willing, please enter your contact information.

T